(Q53621065)

16 May 2018

title

A menopause-specific quality of life questionnaire: development and psychometric properties. (English)

1 reference

16 May 2018

1 reference

1 reference

Psychometric Property

1 reference

7

Guyatt GH

1 reference

16 May 2018

author name string

Hilditch JR

1

1 reference

16 May 2018

Lewis J

2

1 reference

16 May 2018

Peter A

3

1 reference

16 May 2018

van Maris B

4

1 reference

16 May 2018

Ross A

5

1 reference

16 May 2018

Franssen E

6

1 reference

16 May 2018

Norton PG

8

1 reference

16 May 2018

Dunn E

9

1 reference

16 May 2018

publication date

1 July 1996

1 reference

16 May 2018

published in

Maturitas

1 reference

16 May 2018

volume

24

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

161-175

1 reference

16 May 2018

Measurement of quality of life in clinical trials of therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Therapeutic goals: quality and quantity of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Some aspects of sexuality and vaginal symptoms during menopause and their relation to anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

The measurement of life satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

"MENOPAUSAL SYMPTOMS" IN WOMEN OF VARIOUS AGES

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

A factor analytic study of climacteric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

A new methodological approach to the evaluation of quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Quality of life after the menopause: influence of hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Development and testing of a new measure of health status for clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

A methodological framework for assessing health indices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

Measuring health status: what are the necessary measurement properties?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2896%2982006-8

7 January 2021

10.1016/S0378-5122(96)82006-8

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018